Rostra Therapeutics
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$191,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rostra Therapeutics operates in Healthcare & Life Sciences and is based in Glasgow. Its latest recorded funding round was a Grant round in November 2025.
Rostra Therapeutics is a biopharmaceutical company that develops novel anti-infective medicines based on its proprietary Strathclyde Minor Groove Binders (S-MGBs) platform to treat serious infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rostra Therapeutics Comparables
Compare Rostra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Angel Therapeutics | 81% | |
| MyxoBiomedical | 79% | |
| NovaBiotics Ltd | 76% |
For institutional investors. Book with your work email.
Rostra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Nov 13, 2024 | ||||
| Grant | Jun 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rostra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Exeter | Grant |
| Scottish EDGE | Grant |
| Cystic Fibrosis Trust | Grant |
| Medicines Discovery Catapult | Grant |
| LifeArc | Grant |
| CF AMR Syndicate | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Monthly visitors increased 119% MoM, reaching 1.9K.
- Nov 19, 2025
Received grant funding from the University of Exeter.
For institutional investors. Book with your work email.
Rostra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rostra Therapeutics's valuation, stock price, and market status.
Is Rostra Therapeutics a public or private company?
Rostra Therapeutics is a private company.
What is the current stock price of Rostra Therapeutics?
Rostra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rostra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rostra Therapeutics worth (valuation)?
Valuation information for Rostra Therapeutics is not publicly available.
Can I buy Rostra Therapeutics stock?
Rostra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rostra Therapeutics's last funding round?
Rostra Therapeutics's most recent funding round was Grant on November 19, 2025.
Who are the main investors in Rostra Therapeutics?
Key investors in Rostra Therapeutics include University of Exeter, Scottish EDGE, Cystic Fibrosis Trust, Medicines Discovery Catapult, LifeArc.
Will Rostra Therapeutics IPO soon?
No public IPO plans have been announced for Rostra Therapeutics.
How can I track Rostra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rostra Therapeutics's shares on secondary markets.